| 225 | 2 | 70 |
| 下载次数 | 被引频次 | 阅读次数 |
目的:对比分析蛇咬伤救治体系建立前后的毒蛇咬伤救治效果,为蛇咬伤患者临床救治提供参考。方法:本研究纳入2019年4月—2020年10月宜昌市中心人民医院救治的334例中重度蛇咬伤患者,根据是否建立蛇咬伤救治体系,分为对照组138例,观察组196例。对比分析两组患者的就诊时间、诊断时间、抗蛇毒血清使用时间、住院时间、医疗费用及相关治疗效果。结果:与对照组相比,观察组患者的就诊时间(3.12±1.21 h vs 5.32±1.70 h)、诊断时间(29.45±7.37 min vs44.47±10.19 min)、抗蛇毒血清使用时间(6.65±2.69 min vs 12.94±5.64 min)、住院时间(2.25±1.17天vs 4.72±2.00天)明显缩短(均P<0.001),并且医疗费用(2 845.77±580.48元vs 4 962.18±918.92元,P<0.001)明显降低,皮肤肿胀行切排减压(15.82%vs 30.43%,P<0.05)的发生率明显减少,患者的治愈率由83.33%提高到94.90%。结论:蛇咬伤救治体系的建立实现了降本增效,提高了毒蛇咬伤的治愈率,值得在临床推广运用。
Abstract：Objective: To compare and analyze the treatment effect of snakebite before and after the establishment of snakebite treatment system, and to provide reference for the clinical treatment of snakebite patients. Methods: A total of 334 patients with moderate to severe snakebite treated in Yichang Central People's Hospital from April 2019 to October 2020 were included in this study. According to whether the snakebite treatment system was established, patients were divided into the control group(n=138) and the observation group(n=196). The time of treatment and diagnosis, antivenom time, hospital stays, medical expenses and related therapeutic effects of the two groups were compared and analyzed. Results: Compared to the control group, in observation group, the time of treatment(3.12±1.21 h vs 5.32±1.70 h), the time of diagnosis(29.45±7.37 min vs 44.47±10.19 min), the time of antivenom use(6.65±2.69 min vs 12.94±5.64 min), hospital stays(2.25±1.17 d vs 4.72± 2.00 d) and medical expenses(2 845.77±580.48 yuan vs 4 962.18±918.92 yuan) were significantly shortened(all P<0.001). The incidence of skin swelling resection and decompression(15.82% vs 30.43%, P< 0.05) was significantly reduced, and the cure rate of patients was increased from 83.33% to 94.90%. Conclusion: The establishment of snakebite treatment system can reduce costs and improve outcomes, and increased the cure rate of snakebite, which is worthy of clinical popularization and application.
[1] Oliveira A L, Viegas M F, da Silva S L, et al. The chemistry of snake venom and its medicinal potential[J]. Nat Rev Chem, 2022, 6(7):451-469.
[2] Feola A, Marella G L, Carfora A, et al. Snakebite envenoming a challenging diagnosis for the forensic pathologist:a systematic review[J]. Toxins, 2020, 12(11):699.
[3] Tunjic Pejak D, Nesek Adam V, Srzic I. Venomous snakebites in Croatia, clinical presentation, diagnosis and treatment[J]. Acta Clin Croat, 2022, 61(Suppl 1):59-66.
[4] Bawaskar H S, Bawaskar P H. Snakebite envenoming[J]. Lancet, 2019, 393(10167):131.
[5] Pallett S J, Handford C, Wong S M, et al. Necrosis and amputation following the bite of the Bibron’s stiletto snake(Atractaspis bibronii)with a concise review of current literature[J]. Trop Doct, 2022, 52(1):142-146.
[6]林起庆,宋丽,王威,等.蛇伤防治三级管理体系建设的探讨[J].蛇志, 2020, 32(4):397-399.
[7] Soopairin S, Patikorn C, Taychakhoonavudh S. Antivenom preclinical efficacy testing against Asian snakes and their availability in Asia:a systematic review[J]. PLo S One, 2023, 18(7):e0288723.
[8]田飞,张蓉,刘静兰,等.中重度蛇咬伤患者预后影响因素分析[J].巴楚医学, 2020, 3(3):49-54.
[9] Chaves L F, Chuang T W, Sasa M, et al. Snakebites are associated with poverty, weather fluctuations, and El Ni?o[J]. Sci Adv, 2015, 1(8):e1500249.
[10]Warrell D A, Williams D J. Clinical aspects of snakebite envenoming and its treatment in low-resource settings[J]. Lancet, 2023, 401(10385):1382-1398.
[11] Ratanabanangkoon K. Polyvalent snake antivenoms:production strategy and their therapeutic benefits[J].Toxins, 2023, 15(9):517.
[12]Evans D D, Nelson L W. Treating venomous snakebites in the United States:a guide for nurse practitioners[J].Nurse Pract, 2013, 38(7):13-22.
[13]Russell J J, Schoenbrunner A, Janis J E. Snake bite management:a scoping review of the literature[J].Plast Reconstr Surg Glob Open, 2021, 9(4):e3506.
[14]Lu H Y, Mao Y C, Liu P Y, et al. Clinical predictors of early surgical intervention in patients with venomous snakebites[J]. Eur J Med Res, 2023, 28(1):131.
[15]von Keudell A G, Weaver M J, Appleton P T, et al.Diagnosis and treatment of acute extremity compartment syndrome[J]. Lancet, 2015, 386(10000):1299-1310.
[16]Laustsen A H, Engmark M, Milbo C, et al. From fangs to pharmacology:the future of snakebite envenoming therapy[J]. Curr Pharm Des, 2016, 22(34):5270-5293.
[17]Yusuf A J, Aleku G A, Bello U R, et al. Prospects and challenges of developing plant-derived snake antivenin natural products:a focus on West Africa[J].Chem Med Chem, 2021, 16(24):3635-3648.
[18]张连江,郑颖,范泉水,等.精制抗眼镜王蛇毒血清的制备[J].中国药学杂志, 2008, 43(5):327-331.
[19]Corbett B, Clark R F. North American snake envenomation[J]. Emerg Med Clin North Am, 2017, 35(2):339-354.
基本信息:
中图分类号:R646
引用信息:
[1]余晓刚,田飞,卢宇豪,等.蛇咬伤救治体系建立前后毒蛇咬伤救治效果分析[J].巴楚医学,2023,6(04):42-46.
基金信息:
湖北省自然科学基金项目(No:2019CFB313); 宜昌市卫生科研资助项目(No:A19-301-02)
2023-12-30
2023-12-30